TG Therapeutics (NKB2.MU) Q2 2026 Earnings

6MayConfirmed
Q2 2026
0.1
0.15
0.19
0.23

Details

Expected EPS
0.23442496999999998
Actual EPS
0.10211999999999999
Surprise EPS
-0.13
Surprise Percent
+56.44%

Description

TG Therapeutics (NKB2.MU) has reported earnings of 0.10211999999999999 per share for Q2 2026.

0 Comments

Share your thoughts